Beatriz Losada, María del Carmen Pantín, Javier de la Rubia, Israel Manzanedo and David Gutiérrez
Colorectal cancer is the second cause of death in Spain (20% diagnosed in stage IV), improving survival in recent years thanks to chemotherapy and metastatic surgeries. With regard to a patient diagnosed with native stage IV KRAS colon adenocarcinoma (peritoneal, hepatic), the subject of cytoreduction with HIPEC (intraperitoneal hyperthermic chemotherapy) and the factors that influence the tumor response are reviewed.
分享此文章